Paul McNab, the EVP of $VIAV, sold 1,595 shares of the company on 08-10-2026 for an estimated $59,605. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.3% of their shares of this class of stock. Following this trade, they now own 13,876 shares of this class of $VIAV stock.
$VIAV Insider Trading Activity
$VIAV insiders have traded $VIAV stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $VIAV stock by insiders over the last 6 months:
- OLEG KHAYKIN (President & CEO) has made 0 purchases and 5 sales selling 221,581 shares for an estimated $10,383,990.
- RICHARD BELLUZZO has made 0 purchases and 3 sales selling 79,943 shares for an estimated $3,493,105.
- LUKE M SCRIVANICH (SVP General Manager OSP) has made 0 purchases and 3 sales selling 24,594 shares for an estimated $936,356.
- DONALD A COLVIN sold 25,000 shares for an estimated $730,750
- KEVIN CHRISTOPHER SIEBERT (SVP Gen. Counsel & Secretary) has made 0 purchases and 2 sales selling 15,519 shares for an estimated $698,577.
- DOUG GILSTRAP sold 10,000 shares for an estimated $550,000
- PAUL MCNAB (EVP, Chief Mktg & Stgy Officer) has made 0 purchases and 3 sales selling 7,873 shares for an estimated $326,273.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$VIAV Hedge Fund Activity
We have seen 287 institutional investors add shares of $VIAV stock to their portfolio, and 231 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 9,509,250 shares (-27.0%) from their portfolio in Q2 2026, for an estimated $454,066,687
- PRICE T ROWE ASSOCIATES INC /MD/ added 8,681,201 shares (+576.6%) to their portfolio in Q1 2026, for an estimated $288,910,369
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 5,897,957 shares (-88.4%) from their portfolio in Q1 2026, for an estimated $196,284,008
- WELLINGTON MANAGEMENT GROUP LLP removed 5,556,301 shares (-50.5%) from their portfolio in Q1 2026, for an estimated $184,913,697
- CAPITAL WORLD INVESTORS removed 4,050,091 shares (-25.9%) from their portfolio in Q1 2026, for an estimated $134,787,028
- WHALE ROCK CAPITAL MANAGEMENT LLC added 3,473,152 shares (+inf%) to their portfolio in Q1 2026, for an estimated $115,586,498
- FMR LLC added 3,282,361 shares (+548.3%) to their portfolio in Q1 2026, for an estimated $109,236,974
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$VIAV Revenue
$VIAV had revenues of $443.1M in Q4 2026. This is an increase of 52.53% from the same period in the prior year.
You can track VIAV financials on Quiver Quantitative's VIAV stock page.
You can access data on VIAV stock through the Quiver Quantitative API.
$VIAV Congressional Stock Trading
Members of Congress have traded $VIAV stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $VIAV stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 05/04, 03/27, 03/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$VIAV Price Targets
Multiple analysts have issued price targets for $VIAV recently. We have seen 5 analysts offer price targets for $VIAV in the last 6 months, with a median target of $66.0.
Here are some recent targets:
- Mehdi Hosseini from Susquehanna set a target price of $66.0 on 07/01/2026
- Mike Genovese from Rosenblatt set a target price of $70.0 on 06/10/2026
- Ryan Koontz from Needham set a target price of $68.0 on 04/30/2026
- Andrew Spinola from UBS set a target price of $60.0 on 04/30/2026
- Dave Kang from B. Riley Securities set a target price of $53.0 on 04/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
